- Research works
- 77 ▲ 115% vs 2013–17
- Citations
- 318 4.2 per fractional work
- Top-10% rate
- 6.5% record average 16.5%
- Open access
- 79% world 28%
Not ranked overall: USV (India) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Business, Management and Accounting, 3.7×. Every wedge is a field page.
- Business, Management and Accounting 3.7×
- Economics, Econometrics and Finance 3.3×
- Pharmacology, Toxicology and Pharmaceutics 3.3×
- Medicine 2.8×
- Decision Sciences 2.2×
- Nursing 1.8×
- Energy 1.5×
- Biochemistry, Genetics and Molecular Biology 1.4×
- Agricultural and Biological Sciences 0.5×
- Dentistry 0.5×
- Health Professions 0.5×
- Immunology and Microbiology 0.3×
- Social Sciences 0.3×
- Engineering 0.2×
- Computer Science 0.1×
- Environmental Science 0.1×
- Psychology 0.1×
Which keywords describe research at USV (India)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Clinical Guidelines, Heart Failure, Cardiovascular Disease, Type 2 Diabetes, Cardiovascular Outcomes and Glucose Control.
- Knowledge Economy
- Cancer Therapy
- Blood Pressure
- Risk Factors
- Metformin
- Fiscal Policy
- Obesity
- Institutional Quality
- Artificial Intelligence
- Medication Adherence
- Hypertension
- Insulin Signaling
- Corporate Governance
- Hypoglycemia
- Type 1 Diabetes
- Cardiovascular Events
- Glucose Control
- Type 2 Diabetes
- Cardiovascular Disease
- Insulin Therapy
- Glycemic Control
- Clinical Guidelines
- Heart Failure
- Cardiovascular Outcomes
- Diabetes
- Diabetes Mellitus
- Continuous Glucose Monitoring
- Oxidative Stress
- Financial Reporting
- Clinical Trials
- Antioxidant
- Metabolic Syndrome
- Innovation
- Insulin Resistance
- AMP-Activated Protein Kinase
- Global Burden
- Neuroprotective
- Antihypertensive Drugs
- Renal Denervation
- Information Asymmetry
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Glycemic Control6▲ 116×4 topics
- Insulin Therapy6▲ 146×3 topics
- Clinical Guidelines5▲ 51×2 topics
- Cardiovascular Disease4▲ 11×12 topics
- Heart Failure4▲ 29×4 topics
- Type 2 Diabetes4▲ 55×3 topics
- Cardiovascular Outcomes4▲ 216×1 topic
- Glucose Control4▲ 216×1 topic
- Diabetes3▲ 15×5 topics
- Cardiovascular Events2▲ 45×3 topics
- Diabetes Mellitus2▲ 28×4 topics
- Type 1 Diabetes2▲ 65×2 topics
- Continuous Glucose Monitoring2▲ 116×1 topic
- Hypoglycemia2▲ 116×1 topic
- Oxidative Stress2▲ 3.0×7 topics
- Corporate Governance2▲ 6.3×5 topics
- Financial Reporting2▲ 40×4 topics
- Insulin Signaling2▲ 54×2 topics
- Clinical Trials2▲ 6.5×4 topics
- Hypertension2▲ 16×5 topics
- Antioxidant1▲ 5.5×4 topics
- Medication Adherence1▲ 72×2 topics
- Metabolic Syndrome1▲ 4.7×7 topics
- Artificial Intelligence1▲ 2.7×5 topics
- Innovation1▲ 3.4×5 topics
- Institutional Quality1▲ 35×2 topics
- Insulin Resistance1▲ 7.7×4 topics
- Obesity1▲ 4.8×5 topics
- AMP-Activated Protein Kinase1▲ 89×1 topic
- Fiscal Policy1▲ 15×2 topics
- Global Burden1▲ 6.1×3 topics
- Metformin1▲ 121×1 topic
- Neuroprotective1▲ 22×3 topics
- Risk Factors1▲ 3.0×2 topics
- Antihypertensive Drugs1▲ 66×1 topic
- Blood Pressure1▲ 51×2 topics
- Renal Denervation1▲ 66×1 topic
- Cancer Therapy1▲ 4.9×2 topics
- Information Asymmetry1▲ 57×2 topics
- Knowledge Economy1▲ 26×2 topics
Which research topics does USV (India) publish most on?
By volume in 2022–2025: Diabetes Treatment and Management, Diabetes Management and Research, Metabolism, Diabetes, and Cancer and Blood Pressure and Hypertension Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 4 works
- 2 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 2 works
- 3 Metabolism, Diabetes, and Cancer Molecular Biology 1 works
- 4 Blood Pressure and Hypertension Studies Cardiology and Cardiovascular Medicine 1 works
- 5 Peptidase Inhibition and Analysis Oncology 1 works
- 6 Antiplatelet Therapy and Cardiovascular Diseases Cardiology and Cardiovascular Medicine 1 works
- 7 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 1 works
- 8 Accounting Education and Careers Accounting 1 works
- 9 Phytochemicals and Medicinal Plants Complementary and alternative medicine 1 works
- 10 Financial Reporting and XBRL Management Information Systems 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has USV (India)'s research output changed?
Output in 2018–2022 was 115% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Mumbai
- Indian Institute of Technology Bombay
- Bhabha Atomic Research Centre
- Tata Institute of Fundamental Research
- University of Mumbai
- Institute of Chemical Technology
- Homi Bhabha National Institute
- Tata Memorial Hospital
- Narsee Monjee Institute of Management Studies
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.